Hyperpolarized xenon MRI may be useful in assessing response to biologic treatment among patients with asthma, according to a ...

The investigational drug demonstrated robust STAT6 degradation in blood and skin that was well tolerated and safe in healthy ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

Biologics have recently been used to treat ECRS and bronchial asthma. Biologics are not indicated for EOM; however, because approximately 10of ECRS cases has concomitant EOM, concomitant EOM ...

Parents of children with moderate-to-severe asthma may have a much-needed treatment option: A new trial finds that an injected monoclonal antibody drug called dupilumab significantly reduces a child's ...

If you or someone you know has chronic asthma do read this article to know how biologics can potentially help in treating the condition ...

All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of ...

The poster presentations will be available on Connect’s website under the Presentations and Publications section.

Children with uncontrolled, moderate to severe asthma used dupilumab or placebo for 52 weeks. The treatment group had significant decreases in annualized exacerbation rates compared with the ...

This review suggests that ILC2s bridge the pathophysiological mechanisms of asthma combined with AD, and making them a promising target. However, to date, despite the availability of dupilumab for the ...